PSA-Test Prostata

Prostate-specific antigen (PSA) blood test for early detection of prostate issues including benign prostatic hyperplasia (BPH) and prostate cancer. Single biomarker blood test. Results within 2-3 days. Recommended for men over 45, or earlier with family history of prostate cancer. Biomarker tested: PSA (Prostate-Specific Antigen) - protein produced by prostate gland, elevated levels may indicate prostate enlargement, inflammation (prostatitis), or cancer. Normal ranges: <4 ng/mL generally normal; 4-10 ng/mL borderline requiring further evaluation; >10 ng/mL higher concern warranting urological consultation. Important notes: PSA can be temporarily elevated by ejaculation (abstain 48 hours before test), cycling, prostate examination, urinary tract infection. Low PSA doesn't completely rule out cancer. Test is screening tool, not diagnostic - elevated levels require follow-up with urologist for digital rectal exam, MRI, or biopsy. Price includes blood draw and 19% VAT. Annual testing recommended for men 50+, starting at 45 with family history or African ancestry. Early detection significantly improves treatment outcomes.

Cancer marker blood tests measure substances produced by cancer cells or by your body in response to cancer. Common markers include PSA (prostate-specific antigen) for prostate cancer screening, CEA (carcinoembryonic antigen) used in colorectal cancer monitoring, CA-125 for ovarian cancer, and AFP (alpha-fetoprotein) for liver cancer. It's important to understand that tumor markers are not diagnostic on their own — elevated levels can have non-cancerous causes, and some cancers don't produce detectable markers. They are most valuable for monitoring treatment response, detecting recurrence, and as part of a broader screening strategy alongside imaging and clinical assessment.